Why Chandigarh is Becoming a Hub for Pharma Franchise and Third-Party Manufacturing

The Indian pharmaceutical sector is booming, and Chandigarh has emerged as a focal point for pharma franchise and third-party manufacturing. Over the past decade, the city has transformed into a strategic hub, outshining many traditional and emerging pharma-centric regions. This remarkable rise can be attributed to a confluence of favorable policies, modern infrastructure, and a thriving ecosystem of innovative companies like Innovexia Lifesciences Pvt Ltd.

Strategic Location and Connectivity

Chandigarh’s geographical positioning gives it a decisive advantage. As the capital of both Punjab and Haryana, and with proximity to Himachal Pradesh and Uttarakhand, two states known for pharmaceutical manufacturing, Chandigarh offers seamless access to major raw materials and logistics networks. The city is well-connected by road, rail, and air, making it ideal for the swift movement of goods through North India and beyond.

Regulatory Support and Business-Friendly Policies

The Punjab and Haryana Governments have launched several incentives such as single-window clearance systems, tax subsidies, and skill development initiatives. The city’s regulatory framework has been tailored for pharmaceutical companies, streamlining the licensing process and fostering a robust business environment especially conducive for franchise and third-party manufacturing models.

Rich Talent Pool and Skilled Workforce

Chandigarh boasts top-tier educational establishments, including the Postgraduate Institute of Medical Education and Research (PGIMER), Punjab University, and several pharmacy colleges. These institutions produce a steady supply of well-qualified pharmacists, researchers, and biotechnologists, catering to the needs of both large-scale manufacturers and innovative startups.

Exemplary Infrastructure

The city’s well-planned industrial estates, high-quality power supply, and reliable water resources create the perfect ecosystem for pharmaceutical manufacturing. The availability of HACCP-certified facilities and compliance with global standards such as WHO-GMP and ISO has attracted leading pharma players and facilitated the growth of ancillary businesses like packaging, logistics, and R&D services.

Innovexia Lifesciences Pvt Ltd: Driving Excellence

Among the companies leading this transformation, Innovexia Lifesciences Pvt Ltd stands out prominently. Headquartered in Chandigarh, Innovexia Lifesciences has built a stellar reputation as a quality-centric pharmaceutical manufacturing and franchise partner. Specializing in a wide range of formulations—including tablets, capsules, ointments, injectables, and syrups—the company adheres to the highest standards of quality and compliance.

Innovexia’s strengths lie in its advanced manufacturing facilities, extensive product portfolio, and strong distribution networks. Through its franchise and third-party manufacturing models, it supports both established businesses and new entrants, offering end-to-end solutions from product development to branding and timely delivery. Their commitment to transparency, technology adoption, and unwavering quality assurance sets them apart in a crowded marketplace.

Chandigarh vs. Other Emerging Pharma Cities

While cities like Pune, Ahmedabad, Hyderabad, Indore, Baddi, Sikkim, and others (among the 49 emerging pharma cities in India) each have unique advantages, Chandigarh’s proposition for pharma franchises and third-party manufacturing is distinguished by several factors:

| City | Advantages | Limitations |
|–||-|
| Chandigarh | Strategic North India hub, skilled workforce, regulatory ease, high-quality infrastructure | High competition |
| Baddi | Large manufacturing base, proximity to raw materials | Limited urban amenities |
| Sikkim | Tax exemptions, low-cost land | Geographical remoteness |
| Hyderabad | Major R&D and biotech hub | More suited to large-scale & biotech, less focus on PCD franchise |
| Ahmedabad | Established pharma clusters, logistics | Growing saturation, higher costs |
| Pune | IT-pharma synergy, strong talent pool | Expensive real estate |
| Indore | Growing pharma cluster, central India location | Still catching up on infrastructure |
| Visakhapatnam | Port access, SEZs | Cyclone/vulnerability risk, less pharma-specific infra |
| Lucknow | Rising as a pharma city, lower operating costs | Early stage, less matured supply chain |

Chandigarh’s real distinguishing factor lies in its synced government-business-academia partnerships, proactive industrial policy, superior living standards, and focus on supporting PCD (Propaganda Cum Distribution) pharma and contract manufacturing. Unlike many cities still developing support systems for third-party manufacturing, Chandigarh provides a ready ecosystem, shortening learning curves and reducing go-to-market times.

Future Outlook

With increasing health awareness, expanding markets, and the rise of specialty drugs, the demand for agile, quality-focused manufacturing and distribution partners is on the rise. Chandigarh, driven by enterprises like Innovexia Lifesciences Pvt Ltd, is poised to lead India’s next phase of pharmaceutical growth, particularly in areas demanding flexibility, innovation, and compliance.

In short, for anyone seeking pharma franchise or third-party manufacturing partnerships, Chandigarh offers an unmatched blend of opportunity, support, and growth potential, setting itself apart from other emerging pharma destinations across India.